J Cancer 2022; 13(10):3137. doi:10.7150/jca.76980 This issue Cite

Erratum

Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum

Yuwan Zhao*, Qiuming Luo*, Jierong Mo*, Jianwei Li, Dongcai Ye, Zhixian Ao, Lixin Chen, Jianjun Liu

Laboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China
*Contributed equally

Citation:
Zhao Y, Luo Q, Mo J, Li J, Ye D, Ao Z, Chen L, Liu J. Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum. J Cancer 2022; 13(10):3137. doi:10.7150/jca.76980. https://www.jcancer.org/v13p3137.htm
Other styles

File import instruction

Corrected-article in J Cancer, Volume 11, 3701


Citation styles

APA
Zhao, Y., Luo, Q., Mo, J., Li, J., Ye, D., Ao, Z., Chen, L., Liu, J. (2022). Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum. Journal of Cancer, 13(10), 3137. https://doi.org/10.7150/jca.76980.

ACS
Zhao, Y.; Luo, Q.; Mo, J.; Li, J.; Ye, D.; Ao, Z.; Chen, L.; Liu, J. Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum. J. Cancer 2022, 13 (10), 3137. DOI: 10.7150/jca.76980.

NLM
Zhao Y, Luo Q, Mo J, Li J, Ye D, Ao Z, Chen L, Liu J. Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum. J Cancer 2022; 13(10):3137. doi:10.7150/jca.76980. https://www.jcancer.org/v13p3137.htm

CSE
Zhao Y, Luo Q, Mo J, Li J, Ye D, Ao Z, Chen L, Liu J. 2022. Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum. J Cancer. 13(10):3137.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.